Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Uterine Prolapse 1Uterine Cervical Neoplasms 1Precancerous Conditions 1Ovarian Neoplasms 1Menstruation Disturbances 1Leiomyoma 1Endometriosis 1Endometrial Neoplasms 1Adenomyosis 1

Interventions

Aminolevulinic Acid 2tirbanibulin 1ruxolitinib 1human papillomavirus vaccine, L1 type 16, 18 1Watchful Waiting 1Transurethral Resection of Prostate 1Toremifene 1Robotic Surgical Procedures 1Pregnancy Tests 1Hysterectomy 1Human Papillomavirus DNA Tests 1Excipients 1Colposcopy 1Celecoxib 1CPI-0610 1Blood Specimen Collection 1Biopsy 1BF-200 ALA 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Precancerous Conditions × Hysterectomy × Clear all
NCT07120945 2026-06-02

Embrace Gyn

Medtronic - MITG

Phase NA Active not recruiting
70 enrolled
GynecologicOther neoplasm

Uterine Cervical Neoplasms, Endometriosis, Leiomyoma, Menstruation Disturbances, Ovarian Neoplasms, Precancerous Conditions, Uterine Prolapse, Endometrial Neoplasms, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡